SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
14 hedge funds and large institutions have $5.86M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.52M | |
| 2 | +$993K | |
| 3 | +$361K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$262K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$252K |
Top Sellers
| 1 | -$213K | |
| 2 | -$168K | |
| 3 | -$54K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$18K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3K |